If you want a clearer framework for recovery without guesswork or trial-and-error start with the Injury, Joint & Recovery Blueprint
10.1210/jc.2012-3237 51 IslamM
Current and Emerging Pharmacotherapy forFibromyalgia
Nobody in the APs Rolodex called that a disaster in the works or warned about a Wild West situation
Creatine may support ATP buffering in selected patients, but suitability depends on age, kidney function, diet, medications, laboratory findings and the broader biochemical pattern
What to Expect Over Time Weeks 12: Decrease in inflammation and discomfort Early improvements in digestion and gut comfort (oral form) Weeks 36: Improved tissue repair and mobility Enhanced recovery and energy levels Weeks 612+: Long-term improvements in joint, tendon, and muscle strength Sustained gut health and systemic support Results vary depending on condition, severity, and consistency of use